Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    17919504 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children
Condition: Eosinophilic Esophagitis
Interventions: Drug: Montelukast;   Other: placebo;   Drug: 5 mg Montelukast
2 Completed Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation
Conditions: Eosinophilic Esophagitis;   Esophageal Stenosis;   Esophageal Dilation;   Esophageal Dilatation
Intervention:
3 Recruiting Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
Conditions: Eosinophilic Gastroenteritis;   Eosinophilic Esophagitis
Intervention:
4 Recruiting Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index
Conditions: Deglutition Disorders;   Esophageal Diseases;   Eosinophilia
Intervention: Other: assessment of disease activity using the EEsAI

Indicates status has not been verified in more than two years